RecruitingNCT05122962

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

Sponsor

Mayo Clinic

Enrollment

300 participants

Start Date

Nov 1, 2021

Study Type

OBSERVATIONAL

Conditions

Tetralogy of Fallot Congenital Heart Disease

Summary

This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Moderate (or greater) PR based on quantitative Doppler echocardiography.
Repaired TOF
Congenital Heart Disease diagnosis including but not limited to Ebstein's anomaly, coarctation of the aorta (COA), Fontan palliation, transposition of the great arteries, congenitally corrected transposition of the great arteries.

Exclusion Criteria2

Pregnant Women
Unable to undergo CMRI

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTRemote Heart Rhythm Monitoring

We will be looking to see if remote heart rhythm monitoring for 30 days at baseline, 12, and 24 months, helps for early identification of adverse cardiac events.